Center for Translational Cardiology and Pragmatic Randomized Trials / Cardiovascular Non-Invasive Imaging Research Laboratory. Led by Prof @TorBiering

Herlev & Gentofte Hospital
Joined August 2020
CTCPR Trials & CIRL retweeted
Replying to @TorBiering
@TorBiering presenting the DAN-RSV expanded cohort results at the Hot Line session at @escardio #esc2026 conference @CTCPR_ Papers now online in @NEJMEvidence evidence.nejm.org/doi/full/1… evidence.nejm.org/doi/full/1…
4
1
9
351
Extremely proud of friend, colleague, and boss, @TorBiering, for receiving the 2026 Danish Society of Cardiology & Danish Heart Foundation @cardio_dk Research Prize! This award is in recognition of his massively innovative, outstanding research efforts - Tor, you’re the man!
4
6
3
33
4,061
Congrats @TorBiering. So well deserved. Brilliant scientist, researcher, colleague and friend. Thanks for inspiring us! @CTCPR_
Extremely proud of friend, colleague, and boss, @TorBiering, for receiving the 2026 Danish Society of Cardiology & Danish Heart Foundation @cardio_dk Research Prize! This award is in recognition of his massively innovative, outstanding research efforts - Tor, you’re the man!
1
3
13
1,166
Today we at @CTCPR_ started recruitment for our most recent GIGA trial, the DAN-ZOSTER trial: clinicaltrials.gov/study/NCT… In DAN-ZOSTER we will randomize 162,000 participants to assess whether a shingles vaccination may reduce the future risk of cardiovascular disease and dementia
2
6
1
14
811
#ACC26 @ACCinTouch delivered this year. Outstanding LBCTs, a tremendous FACC ceremony, a 3rd place in the wellness challenge, and most importantly - good food with great friends! @matslassen @KristofferSkaar @LisaSteenDuus ("Team DAN-RSV") @DLBHATTMD @Ajar_Kochar
1
2
14
906
Star PhD fellow @LisaSteenDuus presenting her findings on DAN-RSV participants with CKD. 13,364/131,379 (10.2%) had CKD RSVpreF reduced event rates among CKD patients with a possible effect modification by eGFR RSVpreF did not reduce kidney outcomes. Stay tuned for the paper!
2
9
549
CTCPR Trials & CIRL retweeted
New paper in @CircAHA 🫀📊 In older adults, poor CKM health was highly prevalent, with ~88% in stage 3–4. ⬆️ CKM stage → worse 🫀 remodeling + higher HF risk 📈 Stage 4 vs 2: >8x higher risk over ~9 years Link: ahajournals.org/doi/10.1161/… @mvaduganathan @TorBiering @CTCPR_
19
42
3,589
Meeting Scandinavian Cardiologists all over the world! Yesterday I met professor Finn Gustafsson (who lives in SF and not DK) in London and today I met professor @dan_atar on the plane to Tokyo. The world is small and full of Scandinavian Cardiologists @CTCPR_ @RigsHeart
2
1
16
387
CTCPR Trials & CIRL retweeted
🫁📐DAN-RSV – Rationale & Design. A @AmericanHeartJ publication RSVpreF protects against RSV disease — but does it reduce severe RSV and cardiorespiratory hospitalizations in older adults? @matslassen and colleagues from @CTCPR_ designed DAN-RSV to answer this. Up to 130,000 adults ≥60y randomized 1:1 to RSVpreF vs no vaccine. Pragmatic. Registry-based. Nationwide digital recruitment. A real-world RCT built to inform future vaccination policy. 📄 Study link: sciencedirect.com/science/ar… @TorBiering @CopCard @RigsHeart @HGHHjerte @Stenodiabetes @niklasdj1 @KristofferSkaar
3
5
222
CTCPR Trials & CIRL retweeted
Higher aldosterone-renin ratios in older adults were linked to increased risk of afib and stroke ❤️‍🩹🧠 These findings support the aldosterone pathway as a promising target for CVD prevention. 🔬💊 Now out in @JAMACardio jamanetwork.com/journals/jam… @mvaduganathan @TorBiering @CTCPR_
2
8
18
1,420
When being away from my family on my birthday, it’s great to have my Boston family to celebrate with! Thanks friends 🙏
1
4
20
2,110
Please find our #THTSimPub in @JCardFail below 👇 In this paper, led by @TarekBekfaniMD, we re-visit the evidence behind HeartLogic and describe all the current and future RCTs which are testing the potential prognostic benefit of HeartLogic guided remote cardiac HF care @CTCPR_
🫀#THTSimPub Alert This 🔥State-of-the-Art Review examines HeartLogic, a multisensor algorithm embedded in existing CIEDs to detect early HF decompensation, as well as the DANLOGIC-HF RCT which will test whether guided management reduces HF events! 🔗 bit.ly/46D91Hv
1
6
439
CTCPR Trials & CIRL retweeted
Inflammation and risk of cardiovascular outcomes in atrial fibrillation and flutter patients: A Nationwide Registry Study @adam_femerling @TorBiering @CTCPR_ heartrhythmjournal.com/artic…
4
7
1,060
CTCPR Trials & CIRL retweeted
Federico Martinón-Torres@fedemartinonFeb 18
High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD) | JACC jacc.org/doi/10.1016/j.jacc.… @TorBiering #galfu #danflu2 #flunity @JACCJournals
3
7
398
CTCPR Trials & CIRL retweeted
🚀 Join the IDC kickoff webinar March 5th! 🥼With Chairs @goeijenbier, @TorBiering and Kirsty Short + expert speakers exploring respiratory infections & NCDs ✅No registration: eswi.org/idc-kickoff 🔗More on the program here : eswi.org/activities/webinars… #NCD #IDC #ESWI
2
2
128
We are hiring yet again👇 This time we are looking for skilled echo technician, interested in clinical research. Come join the most innovative and creative team, and help us in redefining how we should conduct randomized controlled trials in a more efficient and inclusive way.
📣 We’re hiring at @CTCPR_! Looking for a skilled Echo Technician / Echo Nurse to join our research team at Gentofte Hospital. Work in a highly specialized cardiac imaging environment with strong collaboration and focus on quality patient care. 🔗 Apply here: regionh.dk/job/s%C3%B8g-job/… @TorBiering @Stenodiabetes @CopCard @Rigshospitalet @HGHHjerte @HerlevGentofte
3
5
441
CTCPR Trials & CIRL retweeted
🌟 Save the Date! 🌟 Bridging the Gap: Respiratory Infections & NCDs 📅 Kickoff Webinar: 5 March Join IDC Chairs @goeijenbier, @TorBiering & Kirsty Short to explore how respiratory viruses intersect with chronic diseases #IDCNDC #ESWI
2
3
119
CTCPR Trials & CIRL retweeted
In adults 65 to 79 years of age, there appeared to be fewer hospitalizations for influenza or pneumonia with high-dose influenza vaccine than with the standard dose, with a similar incidence of serious adverse events. Full GALFLU trial results and Research Summary: nej.md/46712T2
15
82
13
211
69,451